Full-Time

Medical Science Liaison

Confirmed live in the last 24 hours

Arcellx

Arcellx

51-200 employees

Develops immunotherapies for cell therapy

Biotechnology
Healthcare

Compensation Overview

$195k - $240kAnnually

+ Bonus + Equity Grant

Mid

Remote in USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Customer Service
Requirements
  • Advanced degree in health sciences (PharmD, M.D., or Ph.D. in a medically related field) preferred
  • 2-3 years of relevant experience in the hematologic malignancy therapeutic area and/or cell therapy is desired
  • 2+ years of experience in MSL/Medical Affairs in relevant therapeutic area
  • Familiarity/experience with healthcare systems and access environments
  • Demonstrated ability to partner, influence, and work successfully within and across functions and levels of leadership
  • Excellence in communication and presentations skills with strong personal integrity
  • Agile, adaptable, results orientated
Responsibilities
  • Establish and maintain professional relationships with HCPs (MD, PA, NP, RN, PharmD) within the cell therapy and hematology space via both in-person and virtual interactions
  • Develop and execute territory plans in alignment with Medical Affairs strategies
  • Compliantly partner with field-based teams to optimize HCP support and customer service
  • Deliver approved medical and scientific education relevant to disease state and Arcellx products
  • Share insights from external thought leaders and HCPs to inform the development of medical strategies and the development of future clinical programs
  • Represent Arcellx at medical and scientific conferences
  • Partner with clinical operations to support the execution of clinical trials
  • Domestic travel of approximately 50-70% will be required and candidate would need to live within the territory (TX to FL)
Desired Qualifications
  • Master’s degree in health sciences (RN, RPh, PA, NP, etc.) considered if extensive years of clinical and/or medical affairs experience in relevant therapeutic area is present

Arcellx develops immunotherapies aimed at improving cell therapy for serious diseases. Their products focus on advanced techniques that enhance the body's immune response to fight illnesses. The company collaborates with healthcare providers and research institutions to bring these therapies to patients. Unlike many competitors, Arcellx emphasizes proprietary products and partnerships to drive their research and development efforts. The main goal is to meet unmet medical needs by providing safe and effective treatment options through their innovative approach to cell therapy.

Company Stage

IPO

Total Funding

$194.5M

Headquarters

Gaithersburg, Maryland

Founded

2014

Growth & Insights
Headcount

6 month growth

4%

1 year growth

0%

2 year growth

1%
Simplify Jobs

Simplify's Take

What believers are saying

  • Growing investment in personalized medicine aligns with Arcellx's tailored immunotherapies.
  • Advancements in gene editing like CRISPR enhance precision in engineered cell therapies.
  • Outpatient CAR-T administration could reduce costs and increase accessibility for Arcellx.

What critics are saying

  • Competition from established CAR-T therapies like Abecma and Carvykti could limit market share.
  • Dependency on Gilead's Kite partnership poses risks if partnership dynamics change.
  • Phase 3 iMMagine-3 trial delays or failures could impact anito-cel's market timeline.

What makes Arcellx unique

  • Arcellx's CART-ddBCMA has FDA Fast Track and Orphan Drug designations.
  • The novel D-Domain binder in anito-cel enhances antigen binding and cell killing.
  • ARC-SparX offers dosable and controllable CAR-T therapy options.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Unlimited Paid Time Off

Flexible Work Hours

401(k) Company Match

Fully-Paid Parental Leave

Tuition Reimbursement

Relocation Assistance